Oculis (OCSAW) Financials

$19.08 -3.22 (-14.44%)

As of 05/15/2026 03:30 PM Eastern

Annual Income Statements for Oculis

This table shows Oculis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-17	-20	-42	-106	-95	-125
Consolidated Net Income / (Loss)	-17	-20	-42	-106	-95	-125
Net Income / (Loss) Continuing Operations	-17	-20	-42	-106	-95	-125
Total Pre-Tax Income	-17	-20	-42	-106	-95	-125
Total Operating Income	-14	-14	-35	-94	-78	-101
Total Gross Profit	1.32	1.07	0.99	2.75	3.15	3.74
Total Revenue	1.32	1.07	0.99	2.75	3.15	3.74
Operating Revenue	1.32	1.07	0.99	2.75	3.15	3.74
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	15	16	36	97	81	104
Selling, General & Admin Expense	4.51	5.06	12	21	24	32
Research & Development Expense	11	10	24	35	57	72
Other Operating Expenses / (Income)	-	0.00	-	41	0.00	0.00
Total Other Income / (Expense), net	-2.97	-5.81	-6.78	-11	-16	-24
Interest Expense	2.97	5.60	6.97	1.56	0.70	1.05
Other Income / (Expense), net	-	-0.21	-	-9.63	-16	-23
Income Tax Expense	0.09	0.03	0.06	0.13	-0.18	-0.23
Weighted Average Basic Shares Outstanding	-	-	37.14M	40.90M	47.68M	60.09M
Weighted Average Diluted Shares Outstanding	-	-	37.14M	40.90M	47.68M	60.09M
Weighted Average Basic & Diluted Shares Outstanding	-	-	37.14M	40.90M	47.68M	60.09M

No quarterly income statements for Oculis are available.

This table details how cash moves in and out of Oculis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-8.12	45	-29	154	60	75
Net Cash From Operating Activities	-14	-15	-27	0.14	0.41	76
Net Cash From Continuing Operating Activities	-14	-16	-32	0.14	0.41	76
Net Income / (Loss) Continuing Operations	-17	-20	-42	0.00	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	3.29	4.96	7.82	-0.20	-0.04	76
Net Cash From Investing Activities	-0.02	-0.03	-3.84	0.00	0.00	-0.38
Net Cash From Continuing Investing Activities	-0.02	-0.03	-3.84	0.00	0.00	-0.38
Purchase of Property, Plant & Equipment	-0.02	-0.03	-3.84	-	-	-0.38
Net Cash From Financing Activities	5.49	60	1.85	154	60	0.00
Net Cash From Continuing Financing Activities	5.56	61	2.15	154	60	0.00
Issuance of Common Equity	0.00	0.00	0.00	-	-	0.00
Cash Interest Paid	-	-	-	-	-	0.11
Cash Interest Received	-	-	-	-	-	1.56

No quarterly cash flow statements for Oculis are available.

This table presents Oculis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	63	40	136	133	297
Total Current Assets	52	26	120	116	276
Cash & Equivalents	51	21	46	31	102
Other Current Assets	1.03	3.20	63	84	172
Plant, Property, & Equipment, net	0.47	0.39	0.34	0.42	0.67
Plant, Property & Equipment, gross	0.47	0.39	0.34	0.42	0.67
Total Noncurrent Assets	11	14	16	17	21
Intangible Assets	9.54	13	15	15	17
Other Noncurrent Operating Assets	0.93	0.90	1.00	1.96	4.09
Total Liabilities & Shareholders' Equity	63	40	136	133	297
Total Liabilities	130	146	25	52	50
Total Current Liabilities	4.44	13	23	49	46
Accounts Payable	0.90	4.18	9.04	6.47	2.27
Accrued Expenses	3.33	8.67	7.08	20	25
Other Current Liabilities	0.21	0.15	0.21	0.35	0.63
Total Noncurrent Liabilities	126	133	1.83	3.02	3.96
Capital Lease Obligations	0.63	0.53	0.51	0.95	2.28
Noncurrent Employee Benefit Liabilities	-	-	0.87	2.06	1.68
Total Equity & Noncontrolling Interests	-67	-106	112	81	247
Total Preferred & Common Equity	-66	-106	113	83	249
Preferred Stock	11	12	343	380	695
Total Common Equity	-77	-117	-230	-297	-446
Common Stock	0.37	0.04	0.44	0.49	0.74
Retained Earnings	-79	-120	-238	-315	-485
Treasury Stock	-0.11	-0.00	0.00	-0.01	-0.01
Other Equity Adjustments	1.82	2.67	7.20	17	38

No quarterly balance sheets for Oculis are available.

This table displays calculated financial ratios and metrics derived from Oculis' official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	60,089,344.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	60,089,344.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-2.08
Growth Metrics	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-9.61	-10	-25	-67	-55	-70
Return On Investment Capital (ROIC_SIMPLE)	-	-	-90.84%	-59.60%	-66.97%	-28.27%
Earnings before Interest and Taxes (EBIT)	-14	-15	-35	-105	-94	-124
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-14	-15	-35	-105	-94	-124
Valuation Ratios	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	106	-146	-124	-60	-162
Efficiency Ratios	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	-117	4.70	62	66	164
Increase / (Decrease) in Invested Capital	0.00	-117	121	57	4.66	91
Book Value per Share	$0.00	$0.00	($3.16)	($6.19)	($7.26)	($9.36)
Tangible Book Value per Share	$0.00	$0.00	($3.52)	($6.59)	($7.62)	($9.71)
Total Capital	0.00	-66	27	112	82	249
Total Debt	0.00	0.63	133	0.51	0.95	2.28
Total Long-Term Debt	0.00	0.63	133	0.51	0.95	2.28
Net Debt	0.00	-50	112	-45	-30	-100
Capital Expenditures (CapEx)	0.02	0.03	3.84	0.00	0.00	0.38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-2.58	-8.82	52	36	127
Debt-free Net Working Capital (DFNWC)	0.00	48	13	97	67	230
Net Working Capital (NWC)	0.00	48	13	97	67	230
Net Nonoperating Expense (NNE)	7.18	10	17	39	40	54
Net Nonoperating Obligations (NNO)	0.00	-50	111	-50	-15	-83
Total Depreciation and Amortization (D&A)	0.12	0.10	0.32	0.34	0.45	0.00
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	37.14M	40.90M	47.68M	60.09M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	37.14M	40.90M	47.68M	60.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	37.14M	40.90M	47.68M	60.09M
Normalized Net Operating Profit after Tax (NOPAT)	-9.61	-10	-25	-67	-55	-70
Debt Service Ratios	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-

No quarterly metrics and ratios for Oculis are available.

Financials Breakdown Chart

Oculis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oculis' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Oculis' net income appears to be on an upward trend, with a most recent value of -$124.69 million in 2025, rising from -$16.79 million in 2020. The previous period was -$94.59 million in 2024.

Oculis' total operating income in 2025 was -$100.68 million, based on the following breakdown:

Total Gross Profit: $3.74 million
Total Operating Expenses: $104.42 million

Over the last 5 years, Oculis' total revenue changed from $1.32 million in 2020 to $3.74 million in 2025, a change of 184.2%.

Oculis' total liabilities were at $50.27 million at the end of 2025, a 3.0% decrease from 2024, and a 61.4% decrease since 2021.

In the past 4 years, Oculis' cash and equivalents has ranged from $21.41 million in 2022 to $102.48 million in 2025, and is currently $102.48 million as of their latest financial filing in 2025.

Over the last 5 years, Oculis' book value per share changed from 0.00 in 2020 to -9.36 in 2025, a change of -935.6%.

Related Companies

Financial statements for NASDAQ:OCSAW last updated on 3/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oculis (OCSAW) Financials

Financials Breakdown Chart

Oculis Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oculis (OCSAW) Financials

Annual Income Statements for Oculis

Quarterly Income Statements for Oculis

Annual Cash Flow Statements for Oculis

Quarterly Cash Flow Statements for Oculis

Annual Balance Sheets for Oculis

Quarterly Balance Sheets for Oculis

Annual Metrics And Ratios for Oculis

Quarterly Metrics And Ratios for Oculis

Financials Breakdown Chart

Oculis Financials - Frequently Asked Questions

When does Oculis' fiscal year end?

How has Oculis' net income changed over the last 5 years?

What is Oculis' operating income?

How has Oculis' revenue changed over the last 5 years?

How much debt does Oculis have?

How much cash does Oculis have?

How has Oculis' book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools